A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)
Public ClinicalTrials.gov record NCT06687967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults
Study identification
- NCT ID
- NCT06687967
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Interventions
- Dupilumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 27, 2024
- Primary completion
- Jun 7, 2026
- Completion
- Aug 30, 2026
- Last update posted
- Jul 1, 2026
2024 – 2026
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research Associates - Los Angeles- Site Number : 8400004 | Los Angeles | California | 90045 | — |
| Quality Care Clinical Research- Site Number : 8400034 | Miami | Florida | 33142 | — |
| Michigan Center for Research Company- Site Number : 8400013 | Clarkston | Michigan | 48346 | — |
| JDR Dermatology Research- Site Number : 8400023 | Las Vegas | Nevada | 89145 | — |
| Equity Medical- Site Number : 8400017 | New York | New York | 10023 | — |
| Onsite Clinical Solutions - Huntersville- Site Number : 8400033 | Huntersville | North Carolina | 28078 | — |
| Wake Forest University Health Sciences- Site Number : 8400028 | Winston-Salem | North Carolina | 27104 | — |
| Red River Research Partners - Fargo- Site Number : 8400007 | Fargo | North Dakota | 58103 | — |
| Center for Clinical Studies - Houston - Binz Street- Site Number : 8400011 | Houston | Texas | 77004 | — |
| MedCare Pharma - Houston - Cypress Creek Parkway- Site Number : 8400014 | Houston | Texas | 77090 | — |
| Care Access - Arlington- Site Number : 8400022 | Arlington | Virginia | 22206 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06687967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06687967 live on ClinicalTrials.gov.